ReviewEClinicalMedicine2025
Provision of gender-affirming care for trans and gender-diverse adults: a systematic review of health and quality of life outcomes, values and preferences, and costs.
Review in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Authentic Allyship for Trans and Gender Diverse People: A Patterns of Knowing Perspective in Nursing.Nursing philosophy : an international journal for healthcare professionals · 2026Article
- Course of Testosterone Levels and Potential Biochemical Biomarkers of Androgenization with a Conservative Protocol of Androgen Hormone Therapy in Transgender Males.Journal of clinical medicine · 2026Article
- Education about gender development predicts support for transgender youth's gender identity autonomy.Communications psychology · 2026Article
- Nutritional Monitoring During Gender-Affirming Hormone Therapy: Body Composition and Metabolic Implications.Nutrients · 2026Review
- Venous Thromboembolism in Transgender and Gender Diverse Individuals on Estrogen-Based Gender-Affirming Hormone Therapy.Journal of clinical medicine · 2026Article
- Editorial: Towards Context-Responsive, Evidence-Informed Care for Transgender and Gender Diverse Young People.JAACAP open · 2026Article
- Psychometric validation of the Polish version of the Utrecht Gender Dysphoria Scale - Gender Spectrum questionnaire.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is a substantial evidence base documenting the impact of gender-affirming care on health outcomes among transgender (trans) and gender-diverse people globally, but this rapidly growing body of evidence has not been comprehensively synthesized. Methods: We conducted a systematic review of studies examining outcomes, values and preferences, and costs of gender-affirming care. Protocols were registered in PROSPERO (CRD42024539078 and CRD42024569628). We searched CINAHL, Cochrane Central, Embase, LILACS, PsycINFO, PubMed, and grey literature sources for studies published between 1 January 2018 and 31 March 2024. The outcomes review included data from randomized controlled trials and longitudinal studies that compared health outcomes among adults (age 18+) who received gender-affirming care to those who did not. We synthesized data by subtype (e.g. psychosocial, hormone therapy, surgical) and by study design, using GRADE evidence profiles. We assessed risk of bias with the Cochrane ROB2 and ROBINS-I tools. We summarized values and preferences data qualitatively and provided confidence ratings using GRADE CERQual, and narratively summarized cost data. Findings: Twenty-eight studies, including four randomized controlled trials and 24 longitudinal studies, evaluated health outcomes following gender-affirming care. Moderate to very low certainty evidence from these studies suggests gender-affirming care may improve quality of life, stigma, utilization of health services, and mental health. No studies identified significant negative outcomes or harms. An additional 87 values and preferences studies, six of which also provided cost data, found that gender-affirming care is acceptable and affordable, although costs vary by type of care. Interpretation: Gender-affirming care may improve critical outcomes, including quality of life, among trans and gender-diverse adults who seek this care. Additional data from prospective controlled studies would enhance the evidence base to comprehensively document the impact of gender-affirming care on physical and mental health outcomes. Funding: World Health Organization through a grant from the Elton John AIDS Foundation and the Bill and Melinda Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.